Publication | Closed Access
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Nalbuphine ER Tablets for Uremic Pruritus
94
Citations
18
References
2017
Year
In this largest-to-date randomized controlled trial in uremic pruritus, NAL 120 durably and significantly reduced the itching intensity among hemodialysis patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1